Logo
Login

Company Executives

$ Management Team

Mr. Jason Mitchell

Chief Commercial Officer

Age -
Compensation -
Sex Male

Mr. Patrick Machado

Independent Chairman of the Board

Age 61
Compensation $180.3K USD
Sex Male

Dr. Laurent Fischer

President

Chief Executive Officer

Director

Age 62
Compensation $4.131M USD
Sex Male

Ms. Linda Rubinstein

Chief Financial Officer

Age 58
Compensation $1.606M USD
Sex Female

Mr. Kishor Soparkar

Chief Operating Officer

Age 54
Compensation $1.843M USD
Sex Male

Dr. Rabia Ozden

Chief Medical Officer

Age 57
Compensation $1.305M USD
Sex Female

Dr. Setareh Seyedkazemi

Chief Development Officer

Age 51
Compensation $1.598M USD
Sex Female

Board of Directors

From the proxy statement filed Apr 28, 2025
Directors
10
serving now
Independent
7 of 7
stated in the proxy; 3 not stated
Average tenure
4.5 years
from year joined
CEO also chairs the board
No
Patrick Machado
Director Age On board Independent Committees Other public boards 2024 pay Source
Patrick Machado
Board chair
 61 2017
8 years
 Independent
Audit Committee · Chair Compensation Committee
ACELYRIN, INC., Alumis Inc., Arcus Biosciences, Inc., Xenon Pharmaceuticals Inc. $180,267
Laurent Fischer
CEO, Executive officer
 61 2020
5 years
 Not stated None stated Mirum Pharmaceuticals, Inc, atai Life Sciences, N.V. Paid as CEO
Soo Hong
53 2022
3 years
 Independent
Compensation Committee
None stated Not stated
Szilárd Kiss
50 2024
1 year
 Not stated None stated None stated $180,043
Mark Lupher
54 2019
6 years
 Independent None stated None stated $111,697
C. David Nicholson
70 2023
2 years
 Not stated None stated Actinium Pharmaceuticals, Inc. $106,697
James Scopa
66 2019
6 years
 Independent
Audit Committee
Aligos Therapeutics, Inc. $124,197
Dawn Svoronos
71 2020
5 years
 Independent None stated Xenon Pharmaceuticals Inc., ACELYRIN, INC., Theratechnologies, Inc. $119,197
Reed Tuckson
74 2021
4 years
 Independent None stated Henry Schein, Inc. $111,697
Scott Whitcup
65 2020
5 years
 Independent None stated None stated $119,197

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 28, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans